Skip to content

003120.KS

Ilsung Is Co., Ltd.

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 20,650.00
+0.49%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue65.2B64.3B69.0B78.1B61.2B
Cost of Revenue37.8B37.2B42.0B43.3B33.3B
Gross Profit27.4B27.1B27.0B34.7B27.9B
Operating Expenses
R&D Expense1.3B1.3B354.4M588.1M1.5B
SG&A Expense24.3B21.9B23.1B41.1B14.8B
General & Admin Expense1.4B1.8B2.3B2.6B1.6B
Selling & Marketing Expense20.1B20.1B20.8B20.2B13.2B
Other Expenses6.7B10.1B13.1B829.3M10.3B
Total Operating Expenses32.3B33.2B36.6B42.5B26.6B
Cost and Expenses70.1B70.5B78.5B85.8B60.0B
Operating Income (EBIT)(4.9B)(6.2B)(9.5B)(7.8B)1.3B
Non-Operating
Interest Income5.3B5.6B7.6B8.5B92.1B
Interest Expense41.5M35.4M36.2M23.9M12.6M
Net Interest Income5.3B5.6B7.5B8.4B92.1B
Other Non-Op Income/Expense13.2B9.0B20.7B(13.6B)141.0B
Non-Operating Income (excl Interest)(7.5B)(20.7B)13.6B(141.0B)
EBT (Pre-Tax Income)8.3B2.8B11.2B(21.3B)142.3B
Income Tax Expense2.7B1.7B(1.9B)(404.0M)33.6B
Bottom Line
Net Income5.5B1.2B13.1B(20.9B)108.7B
Earnings from Cont. Ops5.5B1.2B13.1B(20.9B)108.7B
Earnings from Discont. Ops
Bottom Line Net Income5.5B1.2B13.1B(20.9B)108.7B
Per Share
Basic EPS₩571₩170₩1,921(₩2,994)₩2,906
Diluted EPS₩571₩170₩1,921(₩2,994)₩2,906
Revenue Per Share₩9,106₩4,834₩10,126₩11,162₩8,312
Shares
Basic Shares Outstanding7.2M13.3M6.8M7.0M7.4M
Diluted Shares Outstanding7.2M13.3M6.8M7.0M7.4M
Profitability Metrics
EBITDA(3.2B)(2.8B)14.6B(18.2B)145.3B
D&A3.2B3.3B3.4B3.1B3.0B
EBIT(6.5B)(6.2B)11.2B(21.3B)142.3B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026